Dattatrya Shetti - Search Results

Year	Number of Results
2014	1
2019	5
2020	2
2021	1
2022	2
2023	1
2024	0

1

miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3.

Zhang B, Shetti D, Fan C, Wei K. Zhang B, et al. Among authors: shetti d. Biol Res. 2019 Jul 26;52(1):38. doi: 10.1186/s40659-019-0245-4. Biol Res. 2019. PMID: 31349873 Free PMC article.

2

Pristane-induced mammary carcinomas.

Shetti D, Lee BH. Shetti D, et al. Methods Cell Biol. 2021;163:187-195. doi: 10.1016/bs.mcb.2020.10.016. Epub 2020 Nov 25. Methods Cell Biol. 2021. PMID: 33785165

3

Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer.

Pesta M, Shetti D, Kulda V, Knizkova T, Houfkova K, Bagheri MS, Svaton M, Polivka J. Pesta M, et al. Among authors: shetti d. Diagnostics (Basel). 2022 Jul 25;12(8):1799. doi: 10.3390/diagnostics12081799. Diagnostics (Basel). 2022. PMID: 35892510 Free PMC article. Review.

4

Osteopontin as a therapeutic target for cancer.

Bandopadhyay M, Bulbule A, Butti R, Chakraborty G, Ghorpade P, Ghosh P, Gorain M, Kale S, Kumar D, Kumar S, Totakura KV, Roy G, Sharma P, Shetti D, Soundararajan G, Thorat D, Tomar D, Nalukurthi R, Raja R, Mishra R, Yadav AS, Kundu GC. Bandopadhyay M, et al. Among authors: shetti d. Expert Opin Ther Targets. 2014 Aug;18(8):883-95. doi: 10.1517/14728222.2014.925447. Epub 2014 Jun 4. Expert Opin Ther Targets. 2014. PMID: 24899149 Review.

5

Oncogenic Fusions in Gliomas: An Institutional Experience.

Polivka J, Svajdler M, Priban V, Mracek J, Kasik P, Martinek P, Ptakova N, Sharif Bagheri M, Shetti D, Pesta M, Potuznik P, Topolcan O. Polivka J, et al. Among authors: shetti d. Anticancer Res. 2022 Apr;42(4):1933-1939. doi: 10.21873/anticanres.15671. Anticancer Res. 2022. PMID: 35347013

6

Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma.

Bagheri MS, Polivka J, Treskova I, Houfkova K, Knizkova T, Woznica V, Fikrle T, Pivovarcikova K, Svaton M, Shetti D, Negi R, Pesta M. Bagheri MS, et al. Among authors: shetti d. Anticancer Res. 2023 Feb;43(2):695-706. doi: 10.21873/anticanres.16208. Anticancer Res. 2023. PMID: 36697090

7

Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer.

Fan C, Kong F, Shetti D, Zhang B, Yang Y, Wei K. Fan C, et al. Among authors: shetti d. Biochem Biophys Res Commun. 2019 Nov 5;519(2):378-384. doi: 10.1016/j.bbrc.2019.09.016. Epub 2019 Sep 10. Biochem Biophys Res Commun. 2019. PMID: 31519327

8

Erianin Inhibits Proliferation and Induces Apoptosis of HaCaT Cells via ROS-Mediated JNK/c-Jun and AKT/mTOR Signaling Pathways.

Mo C, Shetti D, Wei K. Mo C, et al. Among authors: shetti d. Molecules. 2019 Jul 26;24(15):2727. doi: 10.3390/molecules24152727. Molecules. 2019. PMID: 31357564 Free PMC article.

9

Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.

Shetti D, Zhang B, Fan C, Mo C, Lee BH, Wei K. Shetti D, et al. Cells. 2019 Aug 14;8(8):892. doi: 10.3390/cells8080892. Cells. 2019. PMID: 31416135 Free PMC article.

10

RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer.

Yadav AS , Radharani NNV , Gorain M , Bulbule A , Shetti D , Roy G , Baby T , Kundu GC . Yadav AS , et al. Among authors: shetti d. Nanoscale. 2020 May 21;12(19):10664-10684. doi: 10.1039/c9nr10673a. Epub 2020 May 6. Nanoscale. 2020. PMID: 32374338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year